Asset Comparison and Correlation

Considering 30-days investment horizon, GlaxoSmithKl is expected to generate 1.13 times less return on investment than BristolMyers. But when comparing it to its historical volatility, GlaxoSmithKline plc is 2.44 times less risky than BristolMyers. It trades about 0.21 of its potential returns per unit of risk. BristolMyers Squibb Company is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  4,230  in BristolMyers Squibb Company on April 20, 2013 and sell it today you would earn a total of  100.00  from holding BristolMyers Squibb Company or generate 2.36% return on investment over 30 days.